EL-1804R-1

N/A

Report date: 2023/01/03 10:02:37
NME

Base Information

Drug NameEL-1804R-1
Drug Alias NameEL-1804R-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesElyson Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesElyson Pharmaceutical
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A